Go Pro

Stock Analyst Initiations

Track the latest stock analyst initiations, newly initiated coverage, and first-time analyst ratings in this regularly updated list of analyst recommendations. This page compiles new initiations, including initial stock ratings, buy/hold/sell recommendations, and price targets, so you can monitor all recent coverage openings across the market.

CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetails
CapsoVision, Inc. stock logo
CV
CapsoVision
Initiated by $5.93
-2.1%
$9.00Buy
Moderna, Inc. stock logo
MRNA
Moderna
Initiated by$137.99
-3.3%
Outperform
Moderna, Inc. stock logo
MRNA
Moderna
Initiated by $137.99
-3.3%
Hold
Octave Specialty Group, Inc. stock logo
OSG
Octave Specialty Group
Initiated by $4.61
+2.2%
$8.00Outperform
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
Initiated by$107.17
-4.8%
$120.00Hold
TMC the metals company Inc. stock logo
TMC
TMC the metals
Initiated by $4.81
-5.5%
$10.00Buy
TeraWulf Inc. stock logo
WULF
TeraWulf
Initiated by$15.35
-6.9%
Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 10:45 AM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports  and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.